The story of Viagra and the pharmaceutical industry presents a complex picture for prospective investors. Initially, copyright's remarkable drug revolutionized the treatment of erectile dysfunction, generating substantial profits and shaping the contemporary pharmaceutical landscape. However, intellectual property expiration and the rise of off-bra